心电图在肺动脉高压风险分层中的作用
本研究为单中心前瞻性研究,纳入140例初治PAH或CTEPH患者,分析基线12导联心电图特征与无移植生存的关系。中位随访3.49年,45例(32.5%)死亡或肺移植,异常心电图者无移植生存更差(64.0% vs 86.0%;p=0.037),心率、QRS时限>120 ms及V5导联S波振幅与全因死亡或肺移植相关。
要点
- 仅13.8%的PAH或CTEPH患者心电图正常,正常心电图与较好预后相关。
- QRS时限>120 ms与全因死亡或肺移植风险独立相关(HR 2.61,95%CI 1.01–6.71)。
- 心电图参数可为现有临床指标提供额外预后价值,应纳入风险预测。
核心结论
- 仅13.8%的PAH和CTEPH患者心电图正常,正常心电图与良好结局相关。
- 心电图可为当前临床参数提供额外预后价值,应考虑用于风险预测。
研究设计与样本
- 单中心前瞻性研究,连续纳入初治PAH或CTEPH患者,诊断时采集基线12导联心电图。
- 共纳入140例患者,中位年龄60.7岁,女性占63.6%。
- 采用Kaplan-Meier曲线和Cox比例风险回归评估心电图与无移植生存的关联。
主要发现
- 86.2%患者心电图异常;9.3%无窦性心律,47.8%呈右QRS轴,平均QRS时限101±17 ms。
- 仅42.5%患者复极正常,34.5%有右心室劳损,14.4%为非特异性复极异常。
- 中位随访3.49年(IQR 1.37–6.42),45例(32.5%)死亡或接受肺移植。
- 异常心电图者无移植生存更差(64.0% vs 86.0%;p=0.037)。
- 心率(HR 1.02,95%CI 1.00–1.05)、QRS时限>120 ms(HR 2.61,95%CI 1.01–6.71)及V5导联S波振幅(HR 1.10,95%CI 1.04–1.17)与全因死亡或肺移植相关。
临床怎么用
- 对初治PAH或CTEPH患者应常规行12导联心电图检查并评估异常表现。
- 可将心率、QRS时限>120 ms及V5导联S波振幅纳入风险分层参考。
- 心电图正常提示预后较好,异常心电图需加强随访与风险预测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The prognosis of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) remains dismal. Better risk prediction is needed. This study investigated the prognostic value of ECG characteristics. METHODS: In this single-centre prospective study, consecutive treatment-naïve patients with PAH or CTEPH were included at time of diagnosis. From the 12-lead ECG, obtained at baseline, the following parameters were collected: heart rate (HR), rhythm, QRS axis, conduction times, P-top amplitudes in II, R-top and S-wave amplitudes in V1 and V5 and repolarisation disorders. Associations between the ECG and transplant-free survival was assessed by Kaplan-Meier curves and Cox-proportional hazard regressions. RESULTS: In total, 140 patients were included (median age: 60.7 years, 63.6% female). The ECG was abnormal in 86.2%: sinus rhythm was not present in 9.3%, right QRS axis was observed in 47.8%, mean QRS duration was 101±17 ms. Only 42.5% of the patients had normal repolarisation, 34.5% had right ventricular strain and 14.4% non-specific repolarisation disorders. Over a median follow-up time of 3.49 (IQR: 1.37-6.42) years, 45 patients (32.5%) died or underwent lung transplantation. Transplant-free survival was worse in patients presenting with an abnormal ECG (64.0% vs 86.0%; p=0.037). The following ECG characteristics were associated with all-cause mortality or lung transplantation: heart rate (HR 1.02, 95% CI: 1.00 to 1.05), QRS duration >120 ms (HR 2.61, 95% CI: 1.01 to 6.71) and S-wave amplitude in V5 (HR 1.10, 95% CI: 1.04 to 1.17). CONCLUSION: Only 13.8% of patients with PAH and CTEPH presented with a normal ECG, which is associated with favourable outcome. The ECG provides additional prognostic value to current clinical parameters and should be considered in risk prediction.
引用
- Hendriks PM, Kauling RM, Geenen LW, et al. Role of the electrocardiogram in the risk stratification of pulmonary hypertension. Heart. 2023. PMID: 36171071. doi:10.1136/heartjnl-2022-321475
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。